BAKS Medical develops a medical device specifically designed to manage postpartum hemorrhage, a condition that results in significant blood loss within the first 24 hours after childbirth. This device aims to improve maternal health outcomes in low-resource settings, where access to timely interventions is often limited.
Funding
Funding not disclosed
Founders
Product
Problem
Postpartum hemorrhage (PPH), defined as the loss of one liter or more of blood within the first 24 hours following childbirth, is a leading cause of maternal mortality globally and is often difficult to predict. In low-resource settings, limited access to timely interventions exacerbates the risks associated with PPH.
Solution
BAKS Medical develops innovative medical devices designed to manage postpartum hemorrhage, aiming to improve maternal health outcomes, particularly in areas with limited resources. Their solutions focus on providing effective and accessible interventions to reduce the life-threatening complications associated with excessive blood loss after childbirth. By addressing the challenges of unpredictable and rapid blood loss, BAKS Medical strives to empower healthcare providers with the tools necessary to safeguard maternal well-being.
Target Audience
The primary target audience includes healthcare providers and hospitals in low-resource settings, as well as clinicians focused on maternal health in regions with limited access to advanced medical interventions.
Features
- Medical device specifically designed for the management of postpartum hemorrhage.
- Focus on improving maternal health outcomes in low-resource settings.